BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND HLF, Q16534, 3131, ENSG00000108924
14 results:

  • 1. Comparison of 19G FNA Versus 22G FNB Needles for Endoscopic Ultrasound-Guided Fine-Needle Sampling of Subepithelial Tumors: Is Bigger Better?
    Li J; Feng J; Gao S; Wang W; Huang L; Yi S; Xu H; Ding XW
    J Ultrasound Med; 2024 Apr; 43(4):761-770. PubMed ID: 38167820
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. hlf promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
    Han T; Chen T; Chen L; Li K; Xiang D; Dou L; Li H; Gu Y
    Cell Death Dis; 2023 Sep; 14(9):606. PubMed ID: 37709768
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary adrenal schwannoma: a series of 31 cases emphasizing their clinicopathologic features and favorable prognosis.
    Zhou J; Zhang D; Li W; Zhou L; Xu H; Zheng S; Wang C
    Endocrine; 2019 Sep; 65(3):662-674. PubMed ID: 31278687
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer.
    Sun P; Song Y; Liu D; Liu G; Mao X; Dong B; Braicu EI; Sehouli J
    Sci Rep; 2018 Sep; 8(1):13483. PubMed ID: 30194340
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy.
    Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    J Korean Med Sci; 2017 Dec; 32(12):2021-2028. PubMed ID: 29115086
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.
    Oh J; Barve M; Matthews CM; Koon EC; Heffernan TP; Fine B; Grosen E; Bergman MK; Fleming EL; DeMars LR; West L; Spitz DL; Goodman H; Hancock KC; Wallraven G; Kumar P; Bognar E; Manning L; Pappen BO; Adams N; Senzer N; Nemunaitis J
    Gynecol Oncol; 2016 Dec; 143(3):504-510. PubMed ID: 27678295
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Differentiation of Adrenal Hyperplasia From Adenoma by Use of CT Densitometry and Percentage Washout.
    Park SY; Park BK; Park JJ; Kim CK
    AJR Am J Roentgenol; 2016 Jan; 206(1):106-12. PubMed ID: 26700341
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer.
    Gao Z; Zhang J; Bi M; Han X; Han Z; Wang H; Ou Y
    Int J Clin Exp Pathol; 2015; 8(5):4791-8. PubMed ID: 26191169
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).
    Pearl ML; Dong H; Tulley S; Zhao Q; Golightly M; Zucker S; Chen WT
    Gynecol Oncol; 2015 May; 137(2):229-38. PubMed ID: 25769657
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CT sensitivities for large (≥3 cm) adrenal adenoma and cortical carcinoma.
    Park SY; Park BK; Park JJ; Kim CK
    Abdom Imaging; 2015 Feb; 40(2):310-7. PubMed ID: 25060750
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictive role of nontumoral sodium iodide symporter activity and preoperative thyroid characteristics in remission process of thyroid cancer patients.
    Yildirim-Poyraz N; Yazgan A; Ozdemir E; Gozalan A; Keskin M; Ersoy R; Turkolmez S; Cakir B
    Ann Nucl Med; 2014 Aug; 28(7):623-31. PubMed ID: 24823701
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Antitumor effect of human lactoferrin against newly established human pancreatic cancer cell line SPA].
    Sakamoto N
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1557-63. PubMed ID: 9725049
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Assessment of protein kinase C isozymes by enzyme immunoassay and overexpression of type II in thyroid adenocarcinoma.
    Hagiwara M; Hachiya T; Watanabe M; Usuda N; Iida F; Tamai K; Hidaka H
    Cancer Res; 1990 Sep; 50(17):5515-9. PubMed ID: 1696850
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.